Red Wine Compound Shown To Prevent Prostate Cancer

	Tweet

Researchers at the University of Alabama at Birmingham (UAB) have found that nutrients in red wine may help reduce the risk of developing prostate cancer.

The study involved male mice that were fed a plant compound found in red wine called resveratrol, which has shown anti-oxidant and anti-cancer properties. Other sources of resveratrol in the diet include grapes, raspberries, peanuts and blueberries.

In the study resveratrol-fed mice showed an 87 percent reduction in their risk of developing prostate tumors that contained the worst kind of cancer-staging diagnosis. The mice that proved to have the highest cancer-protection effect earned it after seven months of consuming resveratrol in a powdered formula mixed with their food.

Other mice in the study, those fed resveratrol but still developed a less-serious form of prostate cancer, were 48 percent more likely to have their tumor growth halted or slowed when compared to mice who did not consume the compound, the UAB research team said.

The findings were published in August through the online edition of Carcinogenesis.

This study adds to a growing body of evidence that resveratrol consumption through red wine has powerful chemoprevention properties, in addition to its apparent heart-health benefits, said lead study author Coral Lamartiniere, Ph.D., of UAB’s Department of Pharmacology and Toxicology.

An earlier UAB study published May 2006 in the same journal found resveratrol-fed female mice had considerable reduction in their risk of breast cancer.

Lamartiniere said his research team has been pleasantly surprised at the chemoprevention power of wine and berry polyphenols like resveratrol in animal models.

“A cancer prevention researcher lives for these days when they can make that kind of finding,” Lamartiniere said. “I drink a glass a day every evening because I’m concerned about prostate cancer. It runs in my family.”

Lamartiniere and other researchers say work is already underway to test resveratrol consumption in humans to see what concentrations are needed to convey cancer-prevention benefits.

The amounts used in the UAB mice studies were the equivalent of one person consuming one bottle of red wine per day, which is not advisable. Since drinking alcohol in excessive amounts can have harmful health effects, doctors generally recommend moderate red wine consumption, which is an average of two drinks a day for men and one drink a day for women.

Lamartiniere’s team included researchers from the UAB Department of Pathology and the Comprehensive Cancer Center. Funding support came from the U.S. Department of Defense and the National Cancer Institute.

Media Contact:
Troy Goodman
(205) 934-8938
E-mail:

RELATED STORIES:
Prostate Cancer Patients Sought for Database as Part of Joint Effort   Scientists see progress in prostate cancer tests   Abbott says access to prostate cancer drug widened   ‘Statins’ improve prostate cancer outcome   Swiss study finds income affects prostate cancer patients’ survival   Prostate Cancer Etiology   Pomegranate Juice Slows PSA Acceleration Rate After Prostate Cancer Surgery, Radiation   Genetic mutations associated with increased PSA and prostate cancer   Folate may alter risk of prostate cancer progression   Prostate cancer may respond to more hormone therapy   Study Drug Holds Promise As Alternative to Castration For Early Prostate Cancers   PSA value at 2 years post-treatment can predict long-term survival in prostate cancer patients   Men Who Are Continually Active at Work May Have Decreased Prostate Cancer Risk   PSA screening declines following publication of large trials, guidelines   Soft drink consumption may increase risk of pancreatic cancer   Cholesterol and cancer: Answers and some new questions   Prostate Cancer Grading & Staging   Testicular cancer patients can have children   Early prostate cancer detection, screening: No benefit for men with low baseline PSA value   Genetic factors implicated in survival gap for breast, ovarian or prostate cancer   U.S. Trial Shows No Early Mortality Benefit from Annual Prostate Cancer Screening   Tall men at risk of early prostate cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]